Our findings identify circTGFBR2(3-6) as a novel potentiator of TGF-β/SMAD signaling at the receptor level and highlight IGF2BP3 as a critical m<sup>6</sup>A reader that mediates circTGFBR2(3-6)-driven breast cancer cell plasticity. This evidence concerns the gene IGF2BP3 and breast carcinoma.